Rakuten Aspyrian

Rakuten’s CEO raises $150M to fund his biotech outfit Aspyrian's cancer photoimmunotherapies
Fierce Biotech
Sat, 08/25/18 - 09:34 pm
Rakuten Aspyrian
photoimmunotherapy
head and neck cancer